These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 19095574)
1. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Wagoner MJ; Laronga C; Acs G Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574 [TBL] [Abstract][Full Text] [Related]
2. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Masood S; Loya A; Khalbuss W Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640 [TBL] [Abstract][Full Text] [Related]
3. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA; Derhagopian RP; Martinez P; Gould EW Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [TBL] [Abstract][Full Text] [Related]
4. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q; Montemezzi S; D'Atri C Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [TBL] [Abstract][Full Text] [Related]
5. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated? Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647 [TBL] [Abstract][Full Text] [Related]
7. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758 [TBL] [Abstract][Full Text] [Related]
8. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised? Kunju LP; Kleer CG Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049 [TBL] [Abstract][Full Text] [Related]
9. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS Breast J; 2007; 13(3):251-7. PubMed ID: 17461899 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience. Killebrew LK; Oneson RH Breast J; 2006; 12(4):302-8. PubMed ID: 16848839 [TBL] [Abstract][Full Text] [Related]
11. Predicting cancer on excision of atypical ductal hyperplasia. Doren E; Hulvat M; Norton J; Rajan P; Sarker S; Aranha G; Yao K Am J Surg; 2008 Mar; 195(3):358-61; discussion 361-2. PubMed ID: 18206849 [TBL] [Abstract][Full Text] [Related]
12. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449 [TBL] [Abstract][Full Text] [Related]
13. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650 [TBL] [Abstract][Full Text] [Related]
14. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138 [TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Sie A; Bryan DC; Gaines V; Killebrew LK; Kim CH; Morrison CC; Poller WR; Romilly AP; Schilling K; Sung JH Cancer; 2006 Sep; 107(5):945-9. PubMed ID: 16874817 [TBL] [Abstract][Full Text] [Related]
18. Progression risk of columnar cell lesions of the breast diagnosed in core needle biopsies. Verschuur-Maes AH; Witkamp AJ; de Bruin PC; van der Wall E; van Diest PJ Int J Cancer; 2011 Dec; 129(11):2674-80. PubMed ID: 21225627 [TBL] [Abstract][Full Text] [Related]
19. Underestimation of malignancy of atypical ductal hyperplasia diagnosed on 11-gauge stereotactically guided Mammotome breast biopsy: an Asian breast screen experience. Teng-Swan Ho J; Tan PH; Hee SW; Su-Lin Wong J Breast; 2008 Aug; 17(4):401-6. PubMed ID: 18455920 [TBL] [Abstract][Full Text] [Related]
20. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy. Chae BJ; Lee A; Song BJ; Jung SS World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]